Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
In order to, to achieve the most active action of body energy, it is known that pH of water-containing blood should be maintained at an alkaline of 7.35 to 7.45. More
Biomimic prenatal and postnatal maternal-to-infant transfer of clinical monosaccharides for improved neurologic development and immunologic functions More
Compositions and methods for targeted therapeutic release of encapsulated materials from multi functional liposomes at the site of a solid tumor or a diseased site using ionizing and non-ionizing radiation, a process called conformal Intensity Modulated R More
Related Reports
Market Research Reports provided by reports.iptechex.com
Apr 2011 - 25 pages - $500
Mar 2010 - 414 pages - $690
Jun 2010 - 7 pages - $500
Jan 2011 - 38 pages - $515
Apr 2010 - 42 pages - $515
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Jul 2005 - 52 pages - $515
Feb 2009 - 242 pages - $690
Apr 2010 - 5 pages - $500
Your selection
Browse By
- Industry sector
- Therapeutic device
- Therapeutic medical equipment
- Vision Care
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us